The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis

References

• Grube M, Neis F, Brucker SY, et al. Uterine fibroids - current trends and strategies. Surg Technol Int. 2019;34:257–263.
   PubMedGoogle Scholar
• Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.
   PubMed Web of Science ®Google Scholar
• Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3–9.
   PubMed Web of Science ®Google Scholar
• Mara M, Fucikova Z, Maskova J, et al. Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):226–233.
   PubMed Web of Science ®Google Scholar
• Subramanian S, Clark MA, Isaacson K. Outcome and resource use associated with myomectomy. Obstet Gynecol. 2001;98(4):583–587.
   PubMed Web of Science ®Google Scholar
• Davis MR, Soliman AM, Castelli-Haley J, et al. Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids. J Womens Health (Larchmt). 2018;27(10):1204–1214.
   PubMed Web of Science ®Google Scholar
• Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry. Obstet Gynecol. 2008;111(1):22–33.
   PubMed Web of Science ®Google Scholar
• Vilos GA, Vilos AG, Abu-Rafea B, et al. Interventional uterine-sparing therapies for leiomyomas: a commentary on myolysis. J Obstet Gynaecol Can. 2020;42(2):169–172.
   PubMed Web of Science ®Google Scholar
• Froeling V, Meckelburg K, Schreiter NF, et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol. 2013;82(12):2265–2269.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103–112.
   PubMed Web of Science ®Google Scholar
• Edwards RD, Moss JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356(4):360–370.
   PubMed Web of Science ®Google Scholar
• Manyonda IT, Bratby M, Horst JS, et al. Uterine artery embolization versus myomectomy: impact on quality of life–results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovasc Intervent Radiol. 2012;35(3):530–536.
   PubMed Web of Science ®Google Scholar
• Moss JG, Cooper KG, Khaund A, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG. 2011;118(8):936–944.
   PubMed Web of Science ®Google Scholar
• van der Kooij SM, Hehenkamp WJ, Volkers NA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2010;203(2):105.e1-13.
   PubMed Web of Science ®Google Scholar
• de Bruijn AM, Ankum WM, Reekers JA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol. 2016;215(6):745.e1–745.e12.
   Web of Science ®Google Scholar
• Tropeano G, Di Stasi C, Amoroso S, et al. Incidence and risk factors for clinical failure of uterine leiomyoma embolization. Obstet Gynecol. 2012;120(2 Pt 1):269–276.
   PubMed Web of Science ®Google Scholar
• Joffre F, Tubiana JM, Pelage JP, et al. FEMIC (Fibromes Embolisés aux MICrosphères calibrées): uterine fibroid embolization using tris-acryl microspheres. A French multicenter study. Cardiovasc Intervent Radiol. 2004;27(6):600–606.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Nijenhuis RJ, Verkooijen HM, et al. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. Eur Radiol. 2014;24(10):2649–2657.
   PubMed Web of Science ®Google Scholar
• Lohle PN, Voogt MJ, De Vries J, et al. Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas. J Vasc Interv Radiol. 2008;19(3):319–326.
   PubMed Web of Science ®Google Scholar
• Morita Y, Ito N, Hikida H, et al. Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids – early experience. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):199–203.
   PubMed Web of Science ®Google Scholar
• Scheurig-Muenkler C, Koesters C, Powerski MJ, et al. Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life. J Vasc Interv Radiol. 2013;24(6):765–771.
   PubMed Web of Science ®Google Scholar
• Sone M, Arai Y, Shimizu T, et al. Phase I/II multiinstitutional study of uterine artery embolization with gelatin sponge for symptomatic uterine leiomyomata: Japan Interventional Radiology in Oncology Study Group study. J Vasc Interv Radiol. 2010;21(11):1665–1671.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Faur AV, Wise LA, et al. Predictors of subsequent surgery for uterine leiomyomata after abdominal myomectomy. Obstet Gynecol. 2002;99(3):426–432.
   PubMed Web of Science ®Google Scholar
• Walker WJ, Barton-Smith P. Long-term follow up of uterine artery embolisation–an effective alternative in the treatment of fibroids. BJOG. 2006;113(4):464–468.
   PubMed Web of Science ®Google Scholar
• Duvnjak S, Ravn P, Green A, et al. Clinical long-term outcome and reinterventional rate after uterine fibroid embolization with nonspherical versus spherical polyvinyl alcohol particles. Cardiovasc Intervent Radiol. 2016;39(2):204–209.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328.
   PubMed Web of Science ®Google Scholar
• Narayan A, Lee AS, Kuo GP, et al. Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison. J Vasc Interv Radiol. 2010;21(7):1011–1017.
   PubMed Web of Science ®Google Scholar
• Popovic M, Berzaczy D, Puchner S, et al. Long-term quality of life assessment among patients undergoing uterine fibroid embolization. AJR Am J Roentgenol. 2009;193(1):267–271.
   PubMed Web of Science ®Google Scholar
• Quinn SD, Vedelago J, Gedroyc W, et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:247–251.
   PubMed Web of Science ®Google Scholar
• Walid MS, Heaton RL. Laparoscopic myomectomy: an intent-to-treat study. Arch Gynecol Obstet. 2010;281(4):645–649.
   PubMed Web of Science ®Google Scholar
• Flyckt R, Soto E, Nutter B, et al. Comparison of long-term fertility and bleeding outcomes after robotic-assisted, laparoscopic, and abdominal myomectomy. Obstet Gynecol Int. 2016;2016:2789201.
   PubMed Web of Science ®Google Scholar
• Sangha R, Katukuri V, Palmer M, et al. Recurrence after robotic myomectomy: is it associated with use of GnRH agonist? J Robot Surg. 2016;10(3):245–249.
   PubMed Web of Science ®Google Scholar
• Gorny KR, Borah BJ, Brown DL, et al. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years. J Vasc Interv Radiol. 2014;25(10):1506–1512.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, de Boer JP, Linstra M, et al. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy. Eur Radiol. 2020;30(5):2473–2482.
   PubMed Web of Science ®Google Scholar
• Mohr-Sasson A, Machtinger R, Mashiach R, et al. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors. Am J Obstet Gynecol. 2018;219(4):375.e1–375.e7.
   Web of Science ®Google Scholar
• Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–178.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.
   PubMed Web of Science ®Google Scholar
• Kohi MP, Spies JB. Updates on uterine artery embolization. Semin Intervent Radiol. 2018;35(1):48–55.
   PubMed Web of Science ®Google Scholar
• Keung JJ, Spies JB, Caridi TM. Uterine artery embolization: a review of current concepts. Best Pract Res Clin Obstet Gynaecol. 2018;46:66–73.
   PubMed Web of Science ®Google Scholar
• Izadifar Z, Izadifar Z, Chapman D, et al. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. JCM. 2020;9(2):460.
   Web of Science ®Google Scholar
• Łoziński T, Filipowska J, Gurynowicz G, et al. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data. Int J Hyperthermia. 2019;36(1):582–590.
   PubMed Web of Science ®Google Scholar
• Szkodziak P, Szkodziak F, Trzeciak K, et al. Minimally invasive procedures in the management of uterine fibroids. Prz Menopauzalny. 2017;16(4):122–125.
   PubMedGoogle Scholar
• Zhao WP, Chen JY, Chen WZ. Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images. Exp Ther Med. 2016;11(1):328–334.
   PubMed Web of Science ®Google Scholar